This inventor holds 1 USPTO granted patent. Top assignee: Edge Pharma, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Melissa Lee Bainbridge
Introduction
Melissa Lee Bainbridge is an accomplished inventor based in Colchester, Vermont. She has made significant contributions to the field of medical devices, particularly in the area of cancer treatment. Her innovative work focuses on improving the delivery of chemotherapy drugs, which is crucial for effective bladder cancer treatment.
Latest Patents
Melissa holds a patent for the Mitomycin-C bladder instillation syringe kit. This invention provides compositions, methods, and devices for delivering Mitomycin-C (MMC), an antineoplastic chemotherapy drug used for bladder instillations. The formulation is designed to maintain stability in both acidic and alkaline environments, ensuring that the drug remains effective. The buffered MMC solution is combined with 50% propylene glycol, maintaining a pH from 7.0 to 8.0 when introduced into acidic solutions. This innovative kit can be produced in an FDA registered 503B Outsourcing facility, making it ready for administration with the necessary accessories for bladder instillation.
Career Highlights
Melissa is currently associated with Edge Pharma, LLC, where she continues to develop and refine her inventions. Her work has been instrumental in advancing the field of oncology, particularly in enhancing the delivery mechanisms for chemotherapy drugs.
Collaborations
Melissa has collaborated with notable colleagues, including Brian Thomas Badgley and Sara Jane Nadeau. These partnerships have contributed to the successful development and implementation of her innovative medical solutions.
Conclusion
Melissa Lee Bainbridge's contributions to medical innovation, particularly in cancer treatment, highlight her dedication to improving patient care. Her patented inventions demonstrate the potential for advancements in drug delivery systems, ultimately benefiting those affected by bladder cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile